Partial epilepsy and developmental delay in infant with ring chromosome 14.
G Imataka, M Noguchi, K Tsukada, T Takahashi, H Yamanouchi, O Arisaka
Index: Genet. Couns. 24(1) , 81-3, (2013)
Full Text: HTML
Abstract
Ring chromosome 14 (r14) is clinically characterized by early-onset epilepsy, mental retardation, delayed speech, microcephaly, extremely mild facial dysmorphisms and ophthalmologic abnormalities. We report a case presenting with partial seizures and delayed development in infancy in which r14 was diagnosed based on chromosomal analysis. The patient was a girl with a normal family and delivery history. Afebrile generalized convulsions developed at age 9 months, and phenobarbital was started, but was changed to zonisamide due to impaired liver function. Chromosome analysis led to a diagnosis of 46, XX, r(14) (p11.2q32.3). At age 5 years, while under treatment with zonisamide and clobazam, epilepsy was characterized by multiple daily episodes of complex partial seizures. Although there are no consistent brain MRI or electroencephalogram findings, experienced pediatric neurologists can make a diagnosis based on facial dysmorphisms. When refractory epilepsy is encountered in infancy with developmental delay of unknown cause, chromosome analysis should be performed.
Related Compounds
Related Articles:
2013-09-20
[J. Chromatogr. A. 1308 , 25-31, (2013)]
Zonisamide in clinical practice.
2012-01-01
[Acta Neurol. Scand.,. Suppl.c. (194) , 29-35, (2012)]
Zonisamide in the treatment of bulimia nervosa: an open-label, pilot, prospective study.
2013-11-01
[Int. J. Eat. Disord. 46(7) , 747-50, (2013)]
2013-02-01
[Epilepsy Behav. 26(2) , 170-4, (2013)]
Impact of antiepileptic drugs on genesis of psychosis.
2012-04-01
[Epilepsy Behav. 23(4) , 462-5, (2012)]